Kristin Abate, Chief Accounting Officer: Karyopharm Therapeutics KPTI Sell · Filed 25/10/03

Trade details

Type: Insider sale
Amount: $2,280.6
Shares · price: 362 sh · $6.30 a share
Held after: 10,046 sh
Stock: Karyopharm Therapeutics KPTI
Person: Kristin AbateChief Accounting Officer
Trade date: 25/10/01
Filed: 25/10/03
Days to filing: 2 days

Sold 3.5% of holdings

Share of holding sold: 3.5%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/01~25/10/31

Kristin Abate's recent trades

Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$504
53 sh
$504
Filed 05/15
Traded 05/14
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$5,260
559 sh
$5,260
Filed 03/03
Traded 03/02
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$352
50 sh
$352
Filed 01/29
Traded 01/28
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$1,579
265 sh
$1,579
Filed 01/22
Traded 01/21
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$148
23 sh
$148
Filed 25/09/16
Traded 25/09/15